DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ifoxetine
Ifoxetine
(12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(12) Patent Application Publication (10) Pub. No.: US 2010/0081713 A1 Sharma Et Al
Pharmaceutical Appendix to the Tariff Schedule 2
Marrakesh Agreement Establishing the World Trade Organization
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
WO 2012/056246 Al
Stembook 2018.Pdf
List of SSRI Effects Spirits for MD Widespread Use of Antidepressants
Customs Tariff - Schedule
(12) Patent Application Publication (10) Pub. No.: US 2005/0176680 A1 Lalji Et Al
Supplemental Digital Content 1 Search Strategy (First Conducted on January 17, 2014; Second Retrieval on November 5, 2014)
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Marrakesh Agreement Establishing the World Trade Organization
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
)&F1y3x PHARMACEUTICAL APPENDIX to THE
Customs Tariff - Schedule
Premenstrual Dysphoric Disorder Or Pmdd).Mp
Top View
Customs Tariff - Schedule Xxi - 1
Combination of a Sedative and a Neurotransmitter Modulator, and Methods for Improving Sleep Quality and Treating Depression
| Hai Lama Mtaa Tatu Untuk Tuan Mata Hati
Harmonized Tariff Schedule of the United States (2006) (Rev
United States Patent (19) 11 Patent Number: 5,977,099 Nickolson (45) Date of Patent: Nov
Pipamperone and a Second Agent in Treating Mood and Anxiety Disorders
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Yawning.Txt 24/10/09 20:55
Harmonized Tariff Schedule of the United States (2006) (Rev
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
(12) United States Patent (10) Patent No.: US 6,331,289 B1 Klaveness Et Al
WO 2017/063771 Al 20 April 2017 (20.04.2017) P O P C T
United States Patent (19) 11 Patent Number: 5,922,341 Smith Et Al
Pharmaceutical Appendix to the Tariff Schedule 2
Products Containing Methylcobalamin for the Treatment of Multiple Sclerosis Or Other Demyelinating Conditions
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri